Abstract:Introduction: The landscape of drug-drug interactions (DDIs) has evolved significantly over the past 60 years, necessitating a retrospective analysis to identify research trends and under-explored areas. While methodologies like bibliometric analysis provide valuable quantitative perspectives on DDI research, they have not successfully delineated the complex interrelations between drugs. Understanding these intricate relationships is essential for deciphering the evolving architecture and progressive transformation of DDI research structures over time. We utilize network analysis to unearth the multifaceted relationships between drugs, offering a richer, more nuanced comprehension of shifts in research focus within the DDI landscape. Methods: This groundbreaking investigation employs natural language processing, techniques, specifically Named Entity Recognition (NER) via ScispaCy, and the information extraction model, SciFive, to extract pharmacokinetic (PK) and pharmacodynamic (PD) DDI evidence from PubMed articles spanning January 1962 to July 2023. It reveals key trends and patterns through an innovative network analysis approach. Static network analysis is deployed to discern structural patterns in DDI research, while evolving network analysis is employed to monitor changes in the DDI research trend structures over time. Results: Our compelling results shed light on the scale-free characteristics of pharmacokinetic, pharmacodynamic, and their combined networks, exhibiting power law exponent values of 2.5, 2.82, and 2.46, respectively. In these networks, a select few drugs serve as central hubs, engaging in extensive interactions with a multitude of other drugs. Interestingly, the networks conform to a densification power law, illustrating that the number of DDIs grows exponentially as new drugs are added to the DDI network. Notably, we discovered that drugs connected in PK and PD networks predominantly belong to the same categories defined by the Anatomical Therapeutic Chemical (ATC) classification system, with fewer interactions observed between drugs from different categories. Discussion: The finding suggests that PK and PD DDIs between drugs from different ATC categories have not been studied as extensively as those between drugs within the same categories. By unearthing these hidden patterns, our study paves the way for a deeper understanding of the DDI landscape, providing valuable information for future DDI research, clinical practice, and drug development focus areas.

A novel algorithm for analyzing drug-drug interactions from MEDLINE literature

A Comprehensive Review of Computational Methods for Drug-drug Interaction Detection

Drug—drug interaction through molecular structure similarity analysis

A Review of Approaches for Predicting Drug–Drug Interactions Based on Machine Learning

A Novel Deep Learning Model for Drug-drug Interactions

Informatics confronts drug–drug interactions

DDInter: an online drug–drug interaction database towards improving clinical decision-making and patient safety

Extraction of Pharmacokinetic Evidence of Drug-drug Interactions from the Literature

Tracing the Evolution: A Comprehensive Bibliometric Analysis of Drug Interaction Clinical Studies

An Informatics-based Approach to Identify Key Pharmacological Components in Drug-Drug Interactions

Analysis and prediction of drug–drug interaction by minimum redundancy maximum relevance and incremental feature selection

In Silico Methods for Predicting Drug–drug Interactions with Cytochrome P-450s, Transporters and Beyond

Comprehensive evaluation of deep and graph learning on drug–drug interactions prediction

Deep learning for drug‐drug interaction prediction: A comprehensive review

Detecting high-quality signals of adverse drug-drug interactions from spontaneous reporting data

Revealing the dynamic landscape of drug-drug interactions through network analysis

Novel deep learning-based transcriptome data analysis for drug-drug interaction prediction with an application in diabetes

Comprehensive evaluation of deep and graph learning on drug-drug interactions prediction

Comprehensive Review of Drug-Drug Interaction Prediction Based on Machine Learning: Current Status, Challenges, and Opportunities

Computerized techniques pave the way for drug-drug interaction prediction and interpretation

Systematic Prediction of Pharmacodynamic Drug-Drug Interactions Through Protein-Protein-Interaction Network.